BioElectronics’ ActiPatch® Chronic Pain Therapy Featured In UK’s Leading Daily Mail Newspaper Health Section FREDERICK, MD, USA, March 29, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, announces that its ActiPatch® product’s were featured in the United Kingdom’s leading Daily Mail’s Sunday Health Section, http://www.dailymail.co.uk/health/article-3555221/The-20-pulsing-skin-patch-end-misery-chronic-pain-arthritis-sufferers-diabetics.html. … Continue Reading
BioElectronics President Interviewed by the StockRadio.com
Discusses Bioelectronics Mitigation of Chronic Pain and Drug Use BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, is pleased to release an interview with President, Andy Whelan. The interview can be heard at http://thestockradio.com/andrew-whelan-bioelectronics-corp-biel-2953.html Mr. Whelan explained the science of bioelectronics, the chronic pain market, the far-reaching … Continue Reading
Bioelectronics Compay Update April 7, 2016
BioElectronics Wins “Best OTC Marketing Campaign on a Small Budget” The OTC Bulletin, the leading global trade publication for over-the-counter healthcare products, has chosen ActiPatch® Musculoskeletal Chronic Pain Relief Therapy as the winner for the “Best OTC Marketing Campaign on a Small Budget” award. A panel of six independent over-the-counter marketing experts evaluated the seven … Continue Reading
BioElectronics Drug-free Chronic Pain Therapy Observation Study Results
61% Pain Reduction & Decreases Medication Use in 86% (including opioids) FREDERICK, MD, USA, March 29, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of the drug-free over-the-counter, $30.00 ActiPatch® (www.actipatch.com) Musculoskeletal Pain Therapy medical devices, announced today the completion of a 6-month ActiPatch product observation study conducted in conjunction with its ongoing market … Continue Reading
BioElectronics Appoints Evomed as Australian and New Zealand Distributor
FREDERICK, MD. March 21, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that it has appointed Evomed (www.evomed.com.au) as the distributor for ActiPatch® Musculoskeletal Pain Relief Therapy, Allay® Menstrual Pain Relief Therapy and Smart Insole™ Heel Pain Relief Therapy in Australia and New Zealand. Evomed specializes in the … Continue Reading
BioElectronics Wins “Best OTC Marketing Campaign on a Small Budget”
FREDERICK, MD. March 15, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products, has chosen its ActiPatch® Musculoskeletal Chronic Pain Relief Therapy as the winner for the “Best OTC Marketing Campaign on a Small Budget” award. … Continue Reading
BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress
FREDERICK, MD, USA, March 9, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that a research abstract featuring ActiPatch® will be presented at the British Pain Society annual scientific meeting being held from May 10-12 in Harrogate, UK https://www.britishpainsociety.org/2016-asm/. The Company will also be exhibiting at the … Continue Reading
2016 British Pain Society Annual Scientific Meeting – Harrogate
The 2016 Annual Scientific Meeting will be held 10-12 May in Harrogate, United Kingdom. The British Pain Society invites all healthcare professionals and researchers with an interest in pain to attend their 2016 Annual Scientific Meeting, which will be held Tuesday 10th May – Thursday 12th May at the Harrogate International Centre. The multidisciplinary nature … Continue Reading
BioElectronics and B. Braun Medical Ltd Apply for Prescription Payment Clearance on the UK Drug Tariff
FREDERICK, MD. Feb 18, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that B. Braun has initiated the application for a listing of RecoveryRx® on the National Health Service (NHS) drug tariff (http://www.nhsbsa.nhs.uk/PrescriptionServices/4940.aspx).The UK drug tariff list establishes payment for prescription costs in the UK. “Orthopedic surgeons … Continue Reading
BioElectronics Corporation Refutes SEC Order for Administrative Proceedings
FREDERICK, Md., Feb. 8, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that it is responding to a notice of an order for administrative proceedings from the Securities and Exchange Commission posted on the agency website. “Although neither the Company nor any of the respondents have been … Continue Reading